| Primary |
| Epilepsy |
46.0% |
| Convulsion |
16.7% |
| Petit Mal Epilepsy |
14.7% |
| Hypertension |
4.0% |
| Hiv Infection |
2.7% |
| Partial Seizures |
2.7% |
| Cardiac Disorder |
1.3% |
| Diabetes Mellitus Non-insulin-dependent |
1.3% |
| Encephalopathy |
1.3% |
| Ill-defined Disorder |
1.3% |
| Otitis Media |
1.3% |
| Pain |
1.3% |
| Abdominal Discomfort |
0.7% |
| Antibiotic Prophylaxis |
0.7% |
| Fluid Retention |
0.7% |
| Gastrointestinal Disorder |
0.7% |
| Grand Mal Convulsion |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Myocardial Infarction |
0.7% |
| Myoclonic Epilepsy |
0.7% |
|
| Convulsion |
15.3% |
| Petit Mal Epilepsy |
10.2% |
| Drug Ineffective |
8.5% |
| Grand Mal Convulsion |
5.1% |
| No Adverse Event |
5.1% |
| Pharmaceutical Product Complaint |
5.1% |
| Rash |
5.1% |
| Vomiting |
5.1% |
| Epilepsy |
3.4% |
| Hypoglycaemia |
3.4% |
| Intestinal Obstruction |
3.4% |
| Osteoporosis |
3.4% |
| Poor Quality Drug Administered |
3.4% |
| Priapism |
3.4% |
| Rash Erythematous |
3.4% |
| Rash Pruritic |
3.4% |
| Thinking Abnormal |
3.4% |
| Tic |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
|
| Secondary |
| Epilepsy |
36.1% |
| Convulsion |
16.5% |
| Encephalopathy |
10.3% |
| Product Used For Unknown Indication |
6.2% |
| Drug Use For Unknown Indication |
5.2% |
| Myoclonic Epilepsy |
5.2% |
| Petit Mal Epilepsy |
4.1% |
| Amnesia |
3.1% |
| Bipolar Disorder |
2.1% |
| Grand Mal Convulsion |
2.1% |
| Otitis Media |
2.1% |
| Partial Seizures |
2.1% |
| Contraception |
1.0% |
| Otitis Media Recurrent |
1.0% |
| Panic Attack |
1.0% |
| Partial Epilepsy |
1.0% |
| Skin Discolouration |
1.0% |
|
| Oral Herpes |
13.8% |
| Anxiety |
10.3% |
| Abdominal Pain Upper |
6.9% |
| Death |
6.9% |
| Status Epilepticus |
6.9% |
| Toxic Epidermal Necrolysis |
6.9% |
| Acute Hepatic Failure |
3.4% |
| Back Pain |
3.4% |
| Bipolar I Disorder |
3.4% |
| Convulsion |
3.4% |
| Drug Level Below Therapeutic |
3.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.4% |
| Epilepsy |
3.4% |
| Headache |
3.4% |
| Hypoglycaemia |
3.4% |
| Incorrect Dose Administered |
3.4% |
| Nervousness |
3.4% |
| Pain |
3.4% |
| Panic Attack |
3.4% |
| Petit Mal Epilepsy |
3.4% |
|
| Concomitant |
| Epilepsy |
24.0% |
| Convulsion |
22.0% |
| Product Used For Unknown Indication |
14.0% |
| Renal Transplant |
4.0% |
| Rosacea |
4.0% |
| Osteoporosis |
3.3% |
| Supplementation Therapy |
3.3% |
| Bipolar Disorder |
2.7% |
| Convulsion Prophylaxis |
2.7% |
| Depression |
2.7% |
| Multiple Sclerosis |
2.7% |
| Anxiety |
2.0% |
| Grand Mal Convulsion |
2.0% |
| Hypertension |
2.0% |
| Lennox-gastaut Syndrome |
2.0% |
| Aromatase Inhibition Therapy |
1.3% |
| Arthralgia |
1.3% |
| Back Disorder |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Fibromyalgia |
1.3% |
|
| Vomiting |
11.6% |
| Wrong Technique In Drug Usage Process |
9.3% |
| Convulsion |
7.0% |
| Toxic Epidermal Necrolysis |
7.0% |
| Weight Decreased |
7.0% |
| White Blood Cell Count Decreased |
7.0% |
| Atonic Seizures |
4.7% |
| Breast Haemorrhage |
4.7% |
| Complex Partial Seizures |
4.7% |
| Pharmaceutical Product Complaint |
4.7% |
| Somnolence |
4.7% |
| Tremor |
4.7% |
| Urine Flow Decreased |
4.7% |
| Vitamin D Decreased |
4.7% |
| Abnormal Behaviour |
2.3% |
| Anticonvulsant Drug Level Increased |
2.3% |
| Arthralgia |
2.3% |
| Breast Pain |
2.3% |
| Cholangitis |
2.3% |
| Deformity |
2.3% |
|
| Interacting |
| Epilepsy |
44.4% |
| Hypersomnia |
33.3% |
| Eye Infection |
22.2% |
|
| Convulsion |
33.3% |
| Drug Prescribing Error |
33.3% |
| Epilepsy |
33.3% |
|
